Subgroup analysis of AIP and depression. by Siyi Deng (12887198)

Subjects:

Flowchart of overall study protocol. by Yongwoo Lee (2265172)

Subjects:

Changes in symptom scores and signs of dry eye disease and meibomian gland dysfunction after treatment with intensive pulse light and meibomian gland expression (n =  218). by Yongwoo Lee (2265172)

Subjects:

Change in the vertical distribution of the lipid layer thickness after intensive pulse light treatment (IPL; nm) combined with meibomian gland expression (MGX). by Yongwoo Lee (2265172)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Odds ratio (OR) for depression (HADS-D>=8) with 95% confidence interval (CI). Analyses are run using the weighted survey design on the sub-sample with non-missing for all included... by Maria Lage Barca (4515385)

Subjects:

Potential reduction in number (and %) with depression in the Norwegian 70 + population for year 2023 in the scenarios where loneliness is reduced by 10%, 20%, 30%, 40%, 50%, and 10... by Maria Lage Barca (4515385)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation. by Maria Lage Barca (4515385)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Standardized** prevalence of depression (HADS-D>=8) with 95% CI by sex and year, age 70 + . by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence of depression (HADS-D>=8 with 95% CI) by sex, time, and age group. by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness. by Maria Lage Barca (4515385)

Subjects:

Projections of total number of 70 + yr olds with depression (HADS-D>=8) in Norway for years 2025, 2030, 2035, 2040, 2045, 2050, and 2100. by Maria Lage Barca (4515385)

Subjects:

Sample characteristics among older adults with and without depression (HADS-D>=8) in HUNT2-4. N = 26,512. The HUNT Study, Norway. by Maria Lage Barca (4515385)

Subjects:

Total organic carbon and phenolic content of raw materials and fruit body cultivated (see S2 in S2 File for reference). by Caglar Akcay (6910697)

Subjects:

Spawn run time, earliness, yield, biological efficiency and dry matter of mushroom fruit body (see S1 in S2 File for reference). by Caglar Akcay (6910697)

Subjects: